Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?

Ofei SY; Gariepy C; Hanje J; Sisk T; Daniels CJ; Zaidi AN

doi:10.1016/j.ijcard.2014.12.031

Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?

Ofei SY, Gariepy C, Hanje J, Sisk T, Daniels CJ …

Mots-clés — choisis par les auteurs Congenital heart disease, FibroSure, Fontan, Hepatic fibrosis, Single ventricle

MeSH — NLM indexing Adolescent Adult Female Fontan Procedure / adverse effects Fontan Procedure / trends Humans Liver Cirrhosis / diagnosis Liver Cirrhosis / etiology Male Mass Screening / trends Predictive Value of Tests Severity of Illness Index Young Adult

Actions du personnel

Télécharger le PDF

Les fichiers sont réservés à un usage autorisé dans les canaux partenaires BioPredictive.

Fibrotest Actitest Letter Independent Group United States

Auteurs (6)

Ofei SY — Nationwide Children's Hospital/The Ohio State University, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: sylvia.ofei@nationwidechildrens.org.
Gariepy C — Nationwide Children's Hospital/The Ohio State University, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: cheryl.gariepy@nationwidechildrens.org.
Hanje J — Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: james.hanje@osumc.edu.
Sisk T — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: tracey.sisk@nationwidechildrens.org.
Daniels CJ — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA; Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: curt.daniels@nationwidechildrens.org.

Ofei SY — Nationwide Children's Hospital/The Ohio State University, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: sylvia.ofei@nationwidechildrens.org.
Gariepy C — Nationwide Children's Hospital/The Ohio State University, Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: cheryl.gariepy@nationwidechildrens.org.
Hanje J — Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: james.hanje@osumc.edu.
Sisk T — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA. Electronic address: tracey.sisk@nationwidechildrens.org.
Daniels CJ — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA; Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: curt.daniels@nationwidechildrens.org.
Zaidi AN — Nationwide Children's Hospital/The Ohio State University, The Columbus Ohio Adult Congenital Heart Disease Program (COACH), The Heart Center, Division of Pediatric Cardiology, 700 Children's Drive, Columbus, OH 43205, USA; Wexner Medical Center/The Ohio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, 370 West 9th Avenue, Columbus, OH 43210, USA. Electronic address: azaidi@montefiore.org.

Citation

Ofei SY, Gariepy C, Hanje J, Sisk T, Daniels CJ, Zaidi AN. Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?. Int J Cardiol. 2015;181:174-5. doi:10.1016/j.ijcard.2014.12.031.

Identifiants

DOI: 10.1016/j.ijcard.2014.12.031
PMID: 25528305

Tests

Maladies du foie

Atteintes hépatiques

Comparaisons

Thèmes

Région

Panier

Votre panier est vide.

Parcourez les publications et utilisez Ajouter au panier sur n'importe quelle page de détail pour constituer une archive ZIP à envoyer aux clients.

Parcourir les publications

Liver fibrosis in adults with Fontan palliation: Do common screening studies predict disease severity?

Sur le même sujet

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Noninvasive Assessment of Liver Fibrosis.

Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.

Toward non-invasive assessment strategies in autoimmune hepatitis.